Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy

Methods Mol Biol. 2018:1709:345-357. doi: 10.1007/978-1-4939-7477-1_25.

Abstract

Large heat shock proteins (HSPs) or stress proteins, including Hsp110 and Grp170, are unique molecular chaperones with superior capability of shuttling tumor protein antigens into professional antigen-presenting cells, such as dendritic cells, for highly efficient cross-presentation and T cell priming. Reconstituted chaperone complexes of large HSP and tumor protein antigen have been demonstrated to generate a robust antigen-specific T lymphocyte response with therapeutic potency against multiple cancer types in preclinical models. Here, we describe the methods for preparing this recombinant chaperone complex vaccine and analyzing the vaccine-induced activation of antigen-specific T cells using in vitro and in vivo systems.

Keywords: Antigen cross-presentation; Chaperone vaccine; Grp170; Hsp110; Large heat shock protein; T cell activation.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cancer Vaccines / immunology*
  • Glycoproteins / immunology*
  • HSP110 Heat-Shock Proteins / immunology*
  • HSP70 Heat-Shock Proteins / immunology*
  • Humans
  • Immunotherapy
  • Neoplasm Proteins / immunology
  • Neoplasms / metabolism
  • Neoplasms / therapy
  • Vaccines, Synthetic / immunology*

Substances

  • Cancer Vaccines
  • Glycoproteins
  • HSP110 Heat-Shock Proteins
  • HSP70 Heat-Shock Proteins
  • HSPH1 protein, human
  • Neoplasm Proteins
  • Vaccines, Synthetic
  • glucose-regulated protein 170